Pharmacological Treatment for Agitation in Alzheimer’s Disease? (JAMA)

Summary

Combination dextromethorphan-quinidine shows early signs of being a safe and effective treatment option for Alzheimer’s Disease-related agitation.

Full Text Link

Reference

Cummings, JL. Lyketsos, CG. [and] Peskind, ER. [et al] (2015). Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer Disease dementia: a randomized clinical trial. JAMA: Journal of the American Medical Association. September 22nd – 29th 2015, Vol.314(12), pp.1242-54. (Click here to view the PubMed abstract).

There is a related JAMA editorial, but this is not freely available; a suitable Athens password, a journal subscription or payment is required for access:

Ballard, C. Sharp, S. [and] Corbett, A. (2015). Dextromethorphan and quinidine for treating agitation in patients with Alzheimer Disease dementia. JAMA: Journal of the American Medical Association. September 22nd – 29th 2015, Vol.314(12), pp.1233-5.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Pharmacological Treatments, Quick Insights and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.